| Association of facial paralysis with mRNA COVID-19 vaccines: a disproportionality analysis using the World Health Organization pharmacovigilance database L Renoud, C Khouri, B Revol, M Lepelley, J Perez, M Roustit, ... JAMA Internal Medicine 181 (9), 1243-1245, 2021 | 113 | 2021 |
| Diagnosis and management of central sleep apnea syndrome S Baillieul, B Revol, I Jullian-Desayes, M Joyeux-Faure, R Tamisier, ... Expert review of respiratory medicine 13 (6), 545-557, 2019 | 66 | 2019 |
| Adverse drug reaction risks obtained from meta-analyses and pharmacovigilance disproportionality analyses are correlated in most cases C Khouri, C Petit, M Tod, M Lepelley, B Revol, M Roustit, JL Cracowski Journal of Clinical Epidemiology 134, 14-21, 2021 | 59 | 2021 |
| Impact of concomitant medications on obstructive sleep apnoea I Jullian‐Desayes, B Revol, E Chareyre, P Camus, C Villier, JC Borel, ... British journal of clinical pharmacology 83 (4), 688-708, 2017 | 52 | 2017 |
| Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance–pharmacodynamic study L Cornet, C Khouri, M Roustit, C Guignabert, MC Chaumais, M Humbert, ... European Respiratory Journal 53 (5), 2019 | 51 | 2019 |
| Ticagrelor and central sleep apnea B Revol, I Jullian-Desayes, R Tamisier, V Puel, M Mallaret, ... Journal of the American College of Cardiology 71 (20), 2378-2379, 2018 | 37 | 2018 |
| The opioid epidemic: A worldwide exploratory study using the WHO pharmacovigilance database M Robert, E Jouanjus, C Khouri, N Fouilhé Sam‐Laï, B Revol Addiction 118 (4), 771-775, 2023 | 36 | 2023 |
| Reported adverse drug reactions associated with the use of hydroxychloroquine and chloroquine during the COVID-19 pandemic J Perez, M Roustit, M Lepelley, B Revol, JL Cracowski, C Khouri Annals of Internal Medicine 174 (6), 878-880, 2021 | 32 | 2021 |
| Leveraging the variability of pharmacovigilance disproportionality analyses to improve signal detection performances C Khouri, T Nguyen, B Revol, M Lepelley, A Pariente, M Roustit, ... Frontiers in Pharmacology 12, 668765, 2021 | 30 | 2021 |
| Pharmacokinetic herb‐drug interaction between ginger and crizotinib B Revol, E Gautier‐Veyret, C Arrivé, N Fouilhé Sam‐Laï, A McLeer‐Florin, ... British Journal of Clinical Pharmacology 86 (9), 1892-1893, 2020 | 30 | 2020 |
| High prevalence of spin was found in pharmacovigilance studies using disproportionality analyses to detect safety signals: a meta-epidemiological study A Mouffak, M Lepelley, B Revol, C Bernardeau, F Salvo, A Pariente, ... Journal of Clinical Epidemiology 138, 73-79, 2021 | 27 | 2021 |
| A meta-epidemiological study found lack of transparency and poor reporting of disproportionality analyses for signal detection in pharmacovigilance databases C Khouri, B Revol, M Lepelley, A Mouffak, C Bernardeau, F Salvo, ... Journal of Clinical Epidemiology 139, 191-198, 2021 | 26 | 2021 |
| Who may benefit from diuretics in OSA?: a propensity score-match observational study B Revol, I Jullian-Desayes, S Bailly, R Tamisier, Y Grillet, M Sapène, ... Chest 158 (1), 359-364, 2020 | 26 | 2020 |
| Adverse events of recreational cannabis use reported to the French addictovigilance network (2012–2017) E Bouquet, S Pain, C Eiden, E Jouanjus, N Richard, B Fauconneau, ... British journal of clinical pharmacology 87 (10), 3925-3937, 2021 | 18 | 2021 |
| Baclofen and sleep apnoea syndrome: analysis of VigiBase, the WHO pharmacovigilance database B Revol, I Jullian-Desayes, S Bailly, M Mallaret, R Tamisier, MS Agier, ... European Respiratory Journal 51 (1), 2018 | 17 | 2018 |
| Association of facial paralysis with mRNA COVID-19 vaccines: a disproportionality analysis using the World Health Organization pharmacovigilance database. JAMA Intern Med. 2021 … L Renoud, C Khouri, B Revol, M Lepelley, J Perez, M Roustit, ... | 15 | 2021 |
| Gabapentinoids and sleep apnea syndrome: a safety signal from the WHO pharmacovigilance database B Revol, I Jullian-Desayes, JL Cracowski, R Tamisier, M Mallaret, ... Sleep 42 (2), zsy242, 2019 | 13 | 2019 |
| Impact of the “French Levothyrox crisis” on signal detection in the World Health Organization pharmacovigilance database C Khouri, B Revol, M Lepelley, M Mallaret, JL Cracowski Pharmacoepidemiology and Drug Safety 27 (12), 1427-1428, 2018 | 9 | 2018 |
| Trends in fatal poisoning among drug users in France from 2011 to 2021: an analysis of the DRAMES Register B Revol, T Willeman, M Manceau, V Dumestre-Toulet, JM Gaulier, ... JAMA network open 6 (8), e2331398-e2331398, 2023 | 7 | 2023 |
| Pharmacology of cannabidiol: Red flags, consequences and risks in humans J Micallef, A Batisse, B Revol Therapie 77 (5), 585-590, 2022 | 7 | 2022 |
